Lingua: Tedesco
Editore: Createspace Independent Pub, 2015
ISBN 10: 1517455235 ISBN 13: 9781517455231
Da: medimops, Berlin, Germania
EUR 4,80
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: as new. Wie neu/Like new.
Lingua: Tedesco
Editore: CreateSpace Independent Publishing Platform, 2016
ISBN 10: 1523478705 ISBN 13: 9781523478705
Da: medimops, Berlin, Germania
EUR 5,27
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: very good. Gut/Very good: Buch bzw. Schutzumschlag mit wenigen Gebrauchsspuren an Einband, Schutzumschlag oder Seiten. / Describes a book or dust jacket that does show some signs of wear on either the binding, dust jacket or pages.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 164,50
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 164,50
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Condizione: New. pp. 512.
EUR 140,00
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Novel Developments in Stem Cell Mobilization | Focus on CXCR4 | Stefan Fruehauf (u. a.) | Taschenbuch | xiv | Englisch | 2014 | Humana | EAN 9781489993762 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Condizione: New. pp. 512.
Lingua: Inglese
Editore: Springer New York, Springer New York, 2014
ISBN 10: 1489993762 ISBN 13: 9781489993762
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 168,73
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Recently the CXCR4/CXCL12-axis has been recognized as one of the pivotal adhesion pathways by which hematopoietic stem cells are retained in the bone marrow. CXCR4 antagonists with different chemical specification are being developed. Pharmacology research guides the way to the rational development effective antagonists. One antagonist, plerixafor, is clinically approved now for stem cell mobilization of lymphoma and myeloma patients. This allows patients to receive potentially life-saving treatment which could not have been administered otherwise. Through early clinical studies it was recognized that CXCR4 antagonists also mobilize malignant hematopoetic cells, i.e. leukemia cells. In preclinical studies a sensitization of mobilized leukemic cells to standard cytotoxic chemotherapy could be shown. Clinical studies are under way. CXCR4 antagonists are an exciting new class of compounds which are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented.
Lingua: Inglese
Editore: Springer New York, Springer US, 2012
ISBN 10: 146141959X ISBN 13: 9781461419594
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 168,73
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Recently the CXCR4/CXCL12-axis has been recognized as one of the pivotal adhesion pathways by which hematopoietic stem cells are retained in the bone marrow. CXCR4 antagonists with different chemical specification are being developed. Pharmacology research guides the way to the rational development effective antagonists. One antagonist, plerixafor, is clinically approved now for stem cell mobilization of lymphoma and myeloma patients. This allows patients to receive potentially life-saving treatment which could not have been administered otherwise. Through early clinical studies it was recognized that CXCR4 antagonists also mobilize malignant hematopoetic cells, i.e. leukemia cells. In preclinical studies a sensitization of mobilized leukemic cells to standard cytotoxic chemotherapy could be shown. Clinical studies are under way. CXCR4 antagonists are an exciting new class of compounds which are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented.
Da: Revaluation Books, Exeter, Regno Unito
EUR 238,38
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 512 pages. 9.26x6.11x1.03 inches. In Stock.
Da: Revaluation Books, Exeter, Regno Unito
EUR 239,97
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 496 pages. 9.25x6.25x1.00 inches. In Stock.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 247,03
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. Like New. book.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 249,41
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Like New. Like New. book.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: biblion2, Obersulm, Germania
EUR 29,00
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: fine. Broschiert. Sofortversand aus Deutschland. Artikel wiegt maximal 500g. 61 Seiten.
Lingua: Tedesco
Editore: Createspace Independent Pub, 2015
ISBN 10: 1519170521 ISBN 13: 9781519170521
Da: Revaluation Books, Exeter, Regno Unito
EUR 8,19
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 60 pages. German language. 9.00x6.00x0.14 inches. This item is printed on demand.
Lingua: Tedesco
Editore: Createspace Independent Pub, 2015
ISBN 10: 1519158092 ISBN 13: 9781519158093
Da: Revaluation Books, Exeter, Regno Unito
EUR 8,19
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 66 pages. German language. 9.00x6.00x0.15 inches. This item is printed on demand.
Lingua: Tedesco
Editore: Createspace Independent Pub, 2016
ISBN 10: 1530241960 ISBN 13: 9781530241965
Da: Revaluation Books, Exeter, Regno Unito
EUR 8,78
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 48 pages. German language. 9.00x6.00x0.11 inches. This item is printed on demand.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 126,26
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 126,26
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Springer New York Apr 2014, 2014
ISBN 10: 1489993762 ISBN 13: 9781489993762
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 160,49
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Recently the CXCR4/CXCL12-axis has been recognized as one of the pivotal adhesion pathways by which hematopoietic stem cells are retained in the bone marrow. CXCR4 antagonists with different chemical specification are being developed. Pharmacology research guides the way to the rational development effective antagonists. One antagonist, plerixafor, is clinically approved now for stem cell mobilization of lymphoma and myeloma patients. This allows patients to receive potentially life-saving treatment which could not have been administered otherwise. Through early clinical studies it was recognized that CXCR4 antagonists also mobilize malignant hematopoetic cells, i.e. leukemia cells. In preclinical studies a sensitization of mobilized leukemic cells to standard cytotoxic chemotherapy could be shown. Clinical studies are under way. CXCR4 antagonists are an exciting new class of compounds which are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented. 512 pp. Englisch.
Lingua: Inglese
Editore: Springer New York, Springer New York Feb 2012, 2012
ISBN 10: 146141959X ISBN 13: 9781461419594
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 160,49
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Recently the CXCR4/CXCL12-axis has been recognized as one of the pivotal adhesion pathways by which hematopoietic stem cells are retained in the bone marrow. CXCR4 antagonists with different chemical specification are being developed. Pharmacology research guides the way to the rational development effective antagonists. One antagonist, plerixafor, is clinically approved now for stem cell mobilization of lymphoma and myeloma patients. This allows patients to receive potentially life-saving treatment which could not have been administered otherwise. Through early clinical studies it was recognized that CXCR4 antagonists also mobilize malignant hematopoetic cells, i.e. leukemia cells. In preclinical studies a sensitization of mobilized leukemic cells to standard cytotoxic chemotherapy could be shown. Clinical studies are under way. CXCR4 antagonists are an exciting new class of compounds which are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented. 512 pp. Englisch.
Da: moluna, Greven, Germania
EUR 136,16
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A concise review of the current status of knowledge and future developments of CXCR4 will be presented Contributors are internationally leaders in the field A comprehensive treatment of the subject with numerous color illustrationsR.
Da: moluna, Greven, Germania
EUR 136,16
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A concise review of the current status of knowledge and future developments of CXCR4 will be presented Contributors are internationally leaders in the field A comprehensive treatment of the subject with numerous color illustrationsR.
Da: Majestic Books, Hounslow, Regno Unito
EUR 203,53
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 512 68 Illus. (35 Col.).
Da: preigu, Osnabrück, Germania
EUR 141,20
Quantità: 5 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Novel Developments in Stem Cell Mobilization | Focus on CXCR4 | Stefan Fruehauf (u. a.) | Buch | xiv | Englisch | 2012 | Humana | EAN 9781461419594 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 200,80
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 512.